These emerging therapies , Tirzepatide , represent a remarkable advancement in addressing metabolic dysfunction and possibly associated ailments . They all are grouped as GLP-1 receptor agonists , https://nelljiwk125573.timeblog.net/77437524/tirzepatide-a-comprehensive-examination-into-metabolic-agents